Aisle of Lost Toys

Aisle of Lost Toys

After failing to emerge from Chapter 11 bankruptcy, the iconic toy retailer, Toys ‘R’ Us, is going to liquidate all its stores in the U.S..

The demise of Toys ‘R’ Us hits small toy vendors and makers especially hard as they may not be able to collect the $14 to $15 million owed.  The loss of a major specialty toy retailer like Toys ‘R’ Us also leaves toy makers without a mass distributor or a physical showcase for innovative toys.

This post is based on the Reuters article, ‘Exhausted’ Toys ‘R’ Us suppliers weigh options as huge retailer shuts, by Tracy Rucinski, Richa Naidu and Melissa Fares, March 17, 2018. Image source: Shutterstock / Marko Poplasen.

Discussion Questions

1. What are the impacts of the liquidation of Toys ‘R’ Us on the retailer’s suppliers?

Guidance: Discussion points include loss of a key downstream partner, loss of payment for goods shipped to the retailer, and the effort required to find new partners/mass distributors.

2. What are the impacts on the toy industry’s supply chain of liquidation by Toys ‘R’ Us?

Guidance: The many losses include loss of a mass distributor, loss of a physical showcase for Continue reading

Facebook
Google+
http://ominthenews.com/tag/risk">
Twitter
Is the Medical Supply Chain a Risk to National Security?

Is the Medical Supply Chain a Risk to National Security?

March 24, 2018

Previous OM in the News posts have looked at the IV bag shortage in the medical supply chain, and many other shortages of medications and supplies. The causes of the shortages are many, including quality issues at production facilities, and Hurricane Maria’s damage to production facilities on Puerto Rico.

Shortages in this particular supply chain can have deadly consequences, and the risks need to be addressed.

Over the years, the supply chain for medical products and medicines has become very lean, and many items are manufactured off-shore.  The last penicillin production in the US was in 2004.  Only 10% of the generic drugs used in the U.S. are made onshore, and eighty percent of the active ingredients in medications are produced overseas, mainly India and China.

Considering the length of the supply chain, combined with ongoing shortages, does a lean medical supply chain present a threat to national security?

This post is based on the Wired article, Medicine’s Long, Thin Supply Chain, by Maryn McKenna, March 5, 2018. Image source: Douglas Sacha/Getty Images.

Discussion Questions

1. Should the United States Government develop policies to insure that critical medial products and medicine are produced Continue reading

Facebook
Google+
http://ominthenews.com/tag/risk">
Twitter